Related Experiment Video
Updated: Jan 6, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner
Rune Alexander Høglund1,2,3, Silje Bøen Torsetnes4,5, Andreas Lossius6,7,8
1Department of Neurology, Akershus University Hospital, 1478 Lørenskog, Norway. r.a.hoglund@medisin.uio.no.
Cysteine cathepsins S, L, and B generate T cell-presented peptides from antibodies and proteins. This process, dependent on immunoglobulin heavy chain variable families, is predictable using computational models and relevant for drug design.
Area of Science:
- Immunology
- Biochemistry
- Computational Biology
Background:
- Cysteine cathepsins are vital for adaptive immunity, epitope generation for HLA presentation, and autoantigen degradation.
- Immunoglobulin variable regions are immunogenic, with T cell reactivity studied in diseases and against therapeutic antibodies.
- The processing of immunoglobulins/B cell receptors in antigen-presenting cells remains poorly understood.
Purpose of the Study:
- To investigate the role of cysteine cathepsins in processing monoclonal antibodies and CNS proteins.
- To elucidate the generation of peptides presented by HLA class II molecules from these proteins.
- To develop predictive models for immunoglobulin degradation.
Main Methods:
- In silico analysis using neural network models.
- In vitro experimental proteomics.
- Cellular models of antigen presentation.
Main Results:
- Cysteine cathepsins S, L, and B generate peptides from monoclonal antibodies and CNS proteins, including autoantigens.
- Peptide generation is dependent on immunoglobulin heavy chain variable families.
- Neural network models combined with proteomics predict this degradation process.
Conclusions:
- Cysteine cathepsins play a significant role in generating HLA class II-presented peptides from antibodies and autoantigens.
- Predictive tools for this degradation can be developed and improved.
- Findings impact biotherapeutic drug design and understanding of autoimmune diseases.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
07:31Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
Published on: November 1, 2014